etoposide has been researched along with moxifloxacin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibbons, S; Kaatz, GW; Zloh, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fabian, I; Halperin, D; Levitov, A; Priel, E; Reuveni, D; Shalit, I | 1 |
| Fabian, I; Halperin, D; Priel, E; Reuveni, D; Shalit, I | 1 |
| Bax, BD; Chan, PF; Fosberry, AP; Gwynn, MN; Hibbs, M; Homes, P; Huang, J; Shillings, A; Singh, O; Spitzfaden, C; Srikannathasan, V; Theobald, AJ; Wohlkonig, A | 1 |
| Bax, BD; Chan, PF; Cui, H; Fosberry, AP; Gu, M; Gwynn, MN; Hann, MM; Hibbs, M; Homes, P; Huang, J; Ingraham, K; Pizzollo, J; Shen, C; Shillings, AJ; Spitzfaden, CE; Srikannathasan, V; Stavenger, RA; Tanner, R; Theobald, AJ | 1 |
1 review(s) available for etoposide and moxifloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for etoposide and moxifloxacin
| Article | Year |
|---|---|
Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cell Membrane; Drug Resistance, Microbial; Drug Resistance, Multiple; Ligands; Models, Molecular | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.
Topics: Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Aza Compounds; Caspase 3; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA, Superhelical; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Etoposide; Fluoroquinolones; Humans; Interleukin-1beta; Interleukin-8; Jurkat Cells; Moxifloxacin; Plasmids; Quinolines; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Carcinoma; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Cytotoxins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Inhibitors; Etoposide; Fluoroquinolones; HT29 Cells; Humans; Moxifloxacin; Quinolines; Topoisomerase II Inhibitors | 2010 |
Crystallization and initial crystallographic analysis of covalent DNA-cleavage complexes of Staphyloccocus aureus DNA gyrase with QPT-1, moxifloxacin and etoposide.
Topics: Base Sequence; Crystallization; Crystallography, X-Ray; DNA Cleavage; DNA Gyrase; Etoposide; Fluoroquinolones; Heterocyclic Compounds, 4 or More Rings; Molecular Sequence Data; Moxifloxacin; Spiro Compounds; Staphylococcus aureus | 2015 |
Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Etoposide; Fluoroquinolones; Models, Molecular; Molecular Structure; Moxifloxacin; Staphylococcus aureus; Topoisomerase II Inhibitors | 2015 |